Literature DB >> 30697632

Is Fat Mass Cross-Sectionally Associated with Cortical Aβ Load in the Human Brain?

M Maltais1, P de Souto Barreto, Y Rolland, B Vellas.   

Abstract

OBJECTIVES: The objective of this study was to examine the relationship of fat mass (FM) with brain amyloid (Aβ) load in older adults.
METHODS: Data from the Multidomain Alzheimer's Preventive Trial (MAPT) for Positron emission tomography and dual-energy X-ray absorptiometry (DXA) were used. Linear regressions controlling for appendicular muscle, age, education, clinical dementia rating scale and Apolipoprotein-E were performed to explore the relationships between FM, trunk FM and Aβ-load.
RESULTS: Thirty-nine participants (75.7 ± 4.2 years old) with an average BMI of 27.5 ± 4.0 kg/m2 were analyzed in this study. There were significant and positive associations of both total and trunk FM with Aβ load [0.01 (0.002-0.02) and 0.02 (0.001-0.04), respectively]; however, when adding ApoE-ε4 as a confounder, associations were no longer significant.
CONCLUSIONS: This study has found associations between FM as measured by DXA and cerebral Aβ load, suggesting that excessive FM might be involved in AD pathology.

Entities:  

Keywords:  Obesity; amyloid; brain; fat mass

Mesh:

Substances:

Year:  2019        PMID: 30697632     DOI: 10.1007/s12603-018-1121-6

Source DB:  PubMed          Journal:  J Nutr Health Aging        ISSN: 1279-7707            Impact factor:   4.075


  21 in total

1.  Overweight and obesity worldwide now estimated to involve 1.7 billion people.

Authors:  Mervyn Deitel
Journal:  Obes Surg       Date:  2003-06       Impact factor: 4.129

2.  Obesity is a chronic, relapsing neurochemical disease.

Authors:  G A Bray
Journal:  Int J Obes Relat Metab Disord       Date:  2004-01

3.  BMI, fat mass, abdominal adiposity and visceral fat: where is the 'beef'?

Authors:  C Bouchard
Journal:  Int J Obes (Lond)       Date:  2007-06-05       Impact factor: 5.095

Review 4.  Body mass index in midlife and late-life as a risk factor for dementia: a meta-analysis of prospective studies.

Authors:  K J Anstey; N Cherbuin; M Budge; J Young
Journal:  Obes Rev       Date:  2011-02-23       Impact factor: 9.213

5.  Obesity and vascular risk factors at midlife and the risk of dementia and Alzheimer disease.

Authors:  Miia Kivipelto; Tiia Ngandu; Laura Fratiglioni; Matti Viitanen; Ingemar Kåreholt; Bengt Winblad; Eeva-Liisa Helkala; Jaakko Tuomilehto; Hilkka Soininen; Aulikki Nissinen
Journal:  Arch Neurol       Date:  2005-10

6.  Obesity in middle age and future risk of dementia: a 27 year longitudinal population based study.

Authors:  Rachel A Whitmer; Erica P Gunderson; Elizabeth Barrett-Connor; Charles P Quesenberry; Kristine Yaffe
Journal:  BMJ       Date:  2005-04-29

7.  Apolipoprotein E polymorphisms predict low density lipoprotein cholesterol levels and carotid artery wall thickness but not incident coronary heart disease in 12,491 ARIC study participants.

Authors:  Kelly A Volcik; Ruth Ann Barkley; Richard G Hutchinson; Thomas H Mosley; Gerardo Heiss; A Richey Sharrett; Christie M Ballantyne; Eric Boerwinkle
Journal:  Am J Epidemiol       Date:  2006-06-07       Impact factor: 4.897

8.  Midlife and late-life obesity and the risk of dementia: cardiovascular health study.

Authors:  Annette L Fitzpatrick; Lewis H Kuller; Oscar L Lopez; Paula Diehr; Ellen S O'Meara; W T Longstreth; José A Luchsinger
Journal:  Arch Neurol       Date:  2009-03

9.  Upregulation of Beclin-1 expression and phosphorylation of Bcl-2 and p53 are involved in the JNK-mediated autophagic cell death.

Authors:  Kyung-Jin Park; Seung-Hyun Lee; Chang-Han Lee; Ji-Young Jang; Junho Chung; Myung-Hee Kwon; Yong-Sung Kim
Journal:  Biochem Biophys Res Commun       Date:  2009-03-24       Impact factor: 3.575

10.  Differential modulation of diet-induced obesity and adipocyte functionality by human apolipoprotein E3 and E4 in mice.

Authors:  J M Arbones-Mainar; L A Johnson; M K Altenburg; N Maeda
Journal:  Int J Obes (Lond)       Date:  2008-08-26       Impact factor: 5.095

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.